Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, S. A.
Right arrow Articles by Cesarman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, S. A.
Right arrow Articles by Cesarman, E.
Related Collections
Right arrow Neoplasia
Right arrow Apoptosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 October 2000, Vol. 96, No. 7, pp. 2537-2542

NEOPLASIA

Inhibition of NF-kappa B induces apoptosis of KSHV-infected primary effusion lymphoma cells

Shannon A. Keller, Elaine J. Schattner, and Ethel Cesarman

From the Weill Graduate School of Medical Sciences of Cornell University, and the Departments of Medicine and Pathology of Weill Medical College of Cornell University, New York, NY.

Kaposi sarcoma-associated herpesvirus (KSHV), or human herpervirus 8 (HHV-8), is a gamma -herpesvirus that infects human lymphocytes and is associated with primary effusion lymphoma (PEL). Currently, the role of viral infection in the transformation of PEL cells is unknown. One possibility is that KSHV, like the lymphotropic viruses Epstein-Barr virus (EBV) and human T-cell leukemia virus I (HTLV-I), activates the transcription factor NF-kappa B to promote survival and proliferation of infected lymphocytes. To examine this possibility, we assessed NF-kappa B activity in KSHV-infected PEL cell lines and primary tumor specimens by electrophoretic mobility shift assay (EMSA). We observed that NF-kappa B is constitutively activated in all KSHV-infected lymphomas, and consists of 2 predominant complexes, p65/p50 heterodimers and p50/p50 homodimers. Inhibition experiments demonstrated that Bay 11-7082, an irreversible inhibitor of Ikappa Balpha phosphorylation, completely and specifically abrogated the NF-kappa B/DNA binding in PEL cells. PEL cells treated with Bay 11 demonstrated down-regulation of the NF-kappa B inducible cytokine interleukin 6 (IL-6), and apoptosis. These results suggest that NF-kappa B activity is necessary for survival of KSHV-infected lymphoma cells, and that pharmacologic inhibition of NF-kappa B may be an effective treatment for PEL.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman
KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor
Blood, May 1, 2008; 111(9): 4731 - 4740.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Efklidou, R. Bailey, N. Field, M. Noursadeghi, and M. K. Collins
vFLIP from KSHV inhibits anoikis of primary endothelial cells
J. Cell Sci., February 15, 2008; 121(4): 450 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M-Q Du, C M Bacon, and P G Isaacson
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders
J. Clin. Pathol., December 1, 2007; 60(12): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Zou, J. Kawada, L. Pesnicak, and J. I. Cohen
Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells
J. Virol., September 15, 2007; 81(18): 10029 - 10036.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Burke, H. J. Brown, M. D. Marsden, G. Bristol, D. N. Vatakis, and J. A. Zack
Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus
J. Virol., July 15, 2007; 81(14): 7424 - 7434.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sadagopan, N. Sharma-Walia, M. V. Veettil, H. Raghu, R. Sivakumar, V. Bottero, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained NF-{kappa}B Activation during De Novo Infection of Primary Human Dermal Microvascular Endothelial Cells That Is Essential for Viral Gene Expression
J. Virol., April 15, 2007; 81(8): 3949 - 3968.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Jost and J. Ruland
Aberrant NF-{kappa}B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Blood, April 1, 2007; 109(7): 2700 - 2707.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Caselli, S. Fiorentini, C. Amici, D. Di Luca, A. Caruso, and M. G. Santoro
Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-{kappa}B pathway
Blood, April 1, 2007; 109(7): 2718 - 2726.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Ramos, P. Ruiz Jr, L. Ratner, I. M. Reis, C. Brites, C. Pedroso, G. E. Byrne Jr, N. L. Toomey, V. Andela, E. W. Harhaj, et al.
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Blood, April 1, 2007; 109(7): 3060 - 3068.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Zeng, X. Zhang, Z. Huang, L. Cheng, S. Yao, D. Qin, X. Chen, Q. Tang, Z. Lv, L. Zhang, et al.
Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling
J. Virol., March 1, 2007; 81(5): 2401 - 2417.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Blood, March 1, 2007; 109(5): 2174 - 2182.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Arguello, S. Paz, E. Hernandez, C. Corriveau-Bourque, L. M. Fawaz, J. Hiscott, and R. Lin
Leukotriene A4 Hydrolase Expression in PEL Cells Is Regulated at the Transcriptional Level and Leads to Increased Leukotriene B4 Production.
J. Immunol., June 1, 2006; 176(11): 7051 - 7061.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. A. Keller, D. Hernandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E. J. Schattner, and E. Cesarman
NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
Blood, April 15, 2006; 107(8): 3295 - 3302.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Yang, K. I. Amiri, J. R. Burke, J. A. Schmid, and A. Richmond
BMS-345541 Targets Inhibitor of {kappa}B Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor {kappa}B and Mitochondria Pathways
Clin. Cancer Res., February 1, 2006; 12(3): 950 - 960.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Watanabe, T. Ohsugi, M. Shoda, T. Ishida, S. Aizawa, M. Maruyama-Nagai, A. Utsunomiya, S. Koga, Y. Yamada, S. Kamihira, et al.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia
Blood, October 1, 2005; 106(7): 2462 - 2471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Chugh, H. Matta, S. Schamus, S. Zachariah, A. Kumar, J. A. Richardson, A. L. Smith, and P. M. Chaudhary
Constitutive NF-{kappa}B activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice
PNAS, September 6, 2005; 102(36): 12885 - 12890.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kurokawa, S. K. Ghosh, J. C. Ramos, A. M. Mian, N. L. Toomey, L. Cabral, D. Whitby, G. N. Barber, D. P. Dittmer, and W. J. Harrington Jr
Azidothymidine inhibits NF-{kappa}B and induces Epstein-Barr virus gene expression in Burkitt lymphoma
Blood, July 1, 2005; 106(1): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Prakash, O. R. Swamy, X. Peng, Z.-Y. Tang, L. Li, J. E. Larson, J. C. Cohen, J. Gill, G. Farr, S. Wang, et al.
Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis
Blood, May 15, 2005; 105(10): 3987 - 3994.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Godfrey, J. Anderson, A. Papanastasiou, Y. Takeuchi, and C. Boshoff
Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA
Blood, March 15, 2005; 105(6): 2510 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. Jazirehi, S. Huerta-Yepez, G. Cheng, and B. Bonavida
Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-{kappa}B Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis
Cancer Res., January 1, 2005; 65(1): 264 - 276.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. T. Lam, R. E. Davis, J. Pierce, M. Hepperle, Y. Xu, M. Hottelet, Y. Nong, D. Wen, J. Adams, L. Dang, et al.
Small Molecule Inhibitors of I{kappa}B Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling
Clin. Cancer Res., January 1, 2005; 11(1): 28 - 40.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Luft, E. Maraskovsky, M. Schnurr, K. Knebel, M. Kirsch, M. Gorner, R. Skoda, A. D. Ho, P. Nawroth, and A. Bierhaus
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells
Blood, August 15, 2004; 104(4): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Matta and P. M. Chaudhary
Activation of alternative NF-{kappa}B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1{beta}-converting enzyme inhibitory protein (vFLIP)
PNAS, June 22, 2004; 101(25): 9399 - 9404.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. D. Cahir-McFarland, K. Carter, A. Rosenwald, J. M. Giltnane, S. E. Henrickson, L. M. Staudt, and E. Kieff
Role of NF-{kappa}B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells
J. Virol., April 15, 2004; 78(8): 4108 - 4119.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
I. Guasparri, S. A. Keller, and E. Cesarman
KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
J. Exp. Med., April 5, 2004; 199(7): 993 - 1003.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Dai, X.-Y. Pei, M. Rahmani, D. H. Conrad, P. Dent, and S. Grant
Interruption of the NF-{kappa}B pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells
Blood, April 1, 2004; 103(7): 2761 - 2770.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Sun, S. Zachariah, and P. M. Chaudhary
The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-{kappa}B Activation
J. Biol. Chem., December 26, 2003; 278(52): 52437 - 52445.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Shi, C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gingeras, G. Schoolnik, S. Akira, et al.
MyD88 Primes Macrophages for Full-Scale Activation by Interferon-{gamma} yet Mediates Few Responses to Mycobacterium tuberculosis
J. Exp. Med., October 6, 2003; 198(7): 987 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins
KSHV vFLIP binds to IKK-{gamma} to activate IKK
J. Cell Sci., September 15, 2003; 116(18): 3721 - 3728.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Brown, M. J. Song, H. Deng, T.-T. Wu, G. Cheng, and R. Sun
NF-{kappa}B Inhibits Gammaherpesvirus Lytic Replication
J. Virol., August 1, 2003; 77(15): 8532 - 8540.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac
Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Z. Dewan, K. Terashima, M. Taruishi, H. Hasegawa, M. Ito, Y. Tanaka, N. Mori, T. Sata, Y. Koyanagi, M. Maeda, et al.
Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/{gamma}cnull Mice: Suppression by an Inhibitor against NF-{kappa}B
J. Virol., May 1, 2003; 77(9): 5286 - 5294.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Ghosh, C. Wood, L. H. Boise, A. M. Mian, V. V. Deyev, G. Feuer, N. L. Toomey, N. C. Shank, L. Cabral, G. N. Barber, et al.
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B
Blood, March 15, 2003; 101(6): 2321 - 2327.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Sun, H. Matta, and P. M. Chaudhary
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation
Blood, March 1, 2003; 101(5): 1956 - 1961.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Cannon, N. J. Philpott, and E. Cesarman
The Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Has Broad Signaling Effects in Primary Effusion Lymphoma Cells
J. Virol., December 6, 2002; 77(1): 57 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Gutierrez, C. Pipaon, N. Inohara, A. Fontalba, Y. Ogura, F. Prosper, G. Nunez, and J. L. Fernandez-Luna
Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-kappa B Activation
J. Biol. Chem., October 25, 2002; 277(44): 41701 - 41705.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii
Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells
Blood, August 13, 2002; 100(5): 1828 - 1834.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
O. Prakash, Z.-Y. Tang, X. Peng, R. Coleman, J. Gill, G. Farr, and F. Samaniego
Tumorigenesis and Aberrant Signaling in Transgenic Mice Expressing the Human Herpesvirus-8 K1 Gene
J Natl Cancer Inst, June 19, 2002; 94(12): 926 - 935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hideshima, D. Chauhan, P. Richardson, C. Mitsiades, N. Mitsiades, T. Hayashi, N. Munshi, L. Dang, A. Castro, V. Palombella, et al.
NF-kappa B as a Therapeutic Target in Multiple Myeloma
J. Biol. Chem., May 3, 2002; 277(19): 16639 - 16647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Liu, M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary
The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the Ikappa B Kinase Complex
J. Biol. Chem., April 12, 2002; 277(16): 13745 - 13751.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. V. Sharp, H.-W. Wang, A. Koumi, D. Hollyman, Y. Endo, H. Ye, M.-Q. Du, and C. Boshoff
K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus Is Latently Expressed and Binds to HAX-1, a Protein with Antiapoptotic Function
J. Virol., January 15, 2002; 76(2): 802 - 816.
[Abstract] [Full Text] [PDF]